{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T13:51:19Z","timestamp":1791640279030,"version":"4.3.4"},"reference-count":18,"publisher":"Georg Thieme Verlag KG","issue":"05","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropediatrics"],"published-print":{"date-parts":[[2024,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>\n          Objectives\u2003The present study was designed to study the efficacy of sequential dietary therapy with a modified Atkins diet (mAD) followed by low glycemic index treatment (LGIT) in treating drug-resistant epilepsy in children.<\/jats:p><jats:p>\n          Methods\u2003This interventional study was conducted from February 2021 to February 2022 among children aged 6 months to 5 years who had failed to respond to more than two conventional and correctly chosen antiseizure medications. The primary endpoint was the proportion of good responders, that is, children with more than 50% seizure reduction. Secondary outcome measures were the proportion of children with seizure freedom,\u2009&gt;\u200990% seizure reduction, and the nature of parent-reported adverse events.<\/jats:p><jats:p>\n          Results\u2003A total of 45 children were recruited for the study, with 6 children being lost to follow-up at 12 weeks. At 12 weeks, 30 of 39 (76.9%) children were good responders with more than 50% seizure reduction. Of these 30 children, 11 (24.4%) had more than 90% seizure reduction, with 9 (20%) achieving complete spasm freedom. Constipation was the most common side effect of the diet among the enrolled subjects.<\/jats:p><jats:p>\n          Conclusion\u2003Clinicians can consider sequential dietary therapy with a mAD in the first month followed by LGIT in the next 2 months for treating children who could not tolerate mAD beyond 1 month.<\/jats:p>","DOI":"10.1055\/s-0044-1787744","type":"journal-article","created":{"date-parts":[[2024,6,21]],"date-time":"2024-06-21T22:36:17Z","timestamp":1719009377000},"page":"289-293","source":"Crossref","is-referenced-by-count":3,"title":["Sequential Treatment with Modified Atkins Diet and Low Glycemic Index Treatment for Drug-Resistant Epilepsy in Children"],"prefix":"10.1055","volume":"55","author":[{"given":"Aparna","family":"Mulyan","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Pt. B. D. Sharma Postgraduate Institute of Medical Sciences, Rohtak, Haryana, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7221-1830","authenticated-orcid":false,"given":"Jaya Shankar","family":"Kaushik","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Pt. B. D. Sharma Postgraduate Institute of Medical Sciences, Rohtak, Haryana, India"},{"name":"Department of Pediatrics, All India Institute of Medical Sciences, Guwahati, Guwahati, Assam, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surekha","family":"Dabla","sequence":"additional","affiliation":[{"name":"Department of Neurology, Pt. B. D. Sharma Postgraduate Institute of Medical Sciences, Rohtak, Haryana, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2024,6,21]]},"reference":[{"issue":"02","key":"ref1","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/epi4.12225","article-title":"Optimal clinical management of children receiving dietary therapies for epilepsy: updated recommendations of the International Ketogenic Diet Study Group","volume":"3","author":"E H Kossoff","year":"2018","journal-title":"Epilepsia Open"},{"issue":"03","key":"ref2","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/epi.12069","article-title":"Use of the modified Atkins diet for treatment of refractory childhood epilepsy: a randomized controlled trial","volume":"54","author":"S Sharma","year":"2013","journal-title":"Epilepsia"},{"issue":"02","key":"ref3","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.seizure.2010.11.010","article-title":"Danish study of a modified Atkins diet for medically intractable epilepsy in children: can we achieve the same results as with the classical ketogenic diet?","volume":"20","author":"M J Miranda","year":"2011","journal-title":"Seizure"},{"issue":"S 08","key":"ref4","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1528-1167.2008.01831.x","article-title":"The modified Atkins diet","volume":"49","author":"E H Kossoff","year":"2008","journal-title":"Epilepsia"},{"issue":"03","key":"ref5","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.yebeh.2013.09.032","article-title":"A decade of the modified Atkins diet (2003\u20132013): Results, insights, and future directions","volume":"29","author":"E H Kossoff","year":"2013","journal-title":"Epilepsy Behav"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.yebeh.2016.12.018","article-title":"Low glycemic index treatment for seizure control in Angelman syndrome: a case series from the Center for Dietary Therapy of Epilepsy at the Massachusetts General Hospital","volume":"68","author":"O R Grocott","year":"2017","journal-title":"Epilepsy Behav"},{"issue":"12","key":"ref7","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1007\/s12098-019-03164-3","article-title":"Non-pharmacological and non-surgical treatment of refractory childhood epilepsy","volume":"87","author":"V Sondhi","year":"2020","journal-title":"Indian J Pediatr"},{"issue":"01","key":"ref8","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1212\/CPJ.0b013e31823d07d1","article-title":"Treating patients with medically resistant epilepsy","volume":"1","author":"G L Krauss","year":"2011","journal-title":"Neurol Clin Pract"},{"issue":"10","key":"ref9","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1001\/jamapediatrics.2020.2282","article-title":"Efficacy of ketogenic diet modified Atkins diet, and low glycemic index therapy diet among children with drug-resistant epilepsy: a randomized clinical trial","volume":"174","author":"V Sondhi","year":"2020","journal-title":"JAMA Pediatr"},{"issue":"01","key":"ref10","doi-asserted-by":"crossref","first-page":"20","DOI":"10.14581\/jer.18004","article-title":"Use of the modified Atkins diet in intractable pediatric epilepsy","volume":"8","author":"E G Park","year":"2018","journal-title":"J Epilepsy Res"},{"issue":"08","key":"ref11","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.braindev.2017.03.027","article-title":"Low glycemic index treatment in patients with drug-resistant epilepsy","volume":"39","author":"S H Kim","year":"2017","journal-title":"Brain Dev"},{"issue":"08","key":"ref12","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.seizure.2013.04.014","article-title":"Clinical spectrum and treatment outcome of West Syndrome in children from Northern India","volume":"22","author":"J S Kaushik","year":"2013","journal-title":"Seizure"},{"issue":"06","key":"ref13","first-page":"492","article-title":"Efficacy of the Atkins diet as therapy for intractable epilepsy in children","volume":"13","author":"S H Tonekaboni","year":"2010","journal-title":"Arch Iran Med"},{"issue":"05","key":"ref14","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1111\/j.1528-1167.2008.01959.x","article-title":"Efficacy, safety, and tolerability of the low glycemic index treatment in pediatric epilepsy","volume":"50","author":"D A Muzykewicz","year":"2009","journal-title":"Epilepsia"},{"issue":"09","key":"ref15","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1007\/s13312-021-2299-y","article-title":"Modified Atkins diet vs low glycemic index treatment for drug-resistant epilepsy in children: an open label, randomized controlled trial","volume":"58","author":"S Gupta","year":"2021","journal-title":"Indian Pediatr"},{"issue":"07","key":"ref16","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.seizure.2014.03.012","article-title":"Low glycemic index treatment in pediatric refractory epilepsy: the first Middle East report","volume":"23","author":"P Karimzadeh","year":"2014","journal-title":"Seizure"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"106574","DOI":"10.1016\/j.eplepsyres.2021.106574","article-title":"Efficacy of low glycemic index diet therapy (LGIT) in children aged 2-8 years with drug-resistant epilepsy: a randomized controlled trial","volume":"171","author":"K Lakshminarayanan","year":"2021","journal-title":"Epilepsy Res"},{"issue":"07","key":"ref18","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.seizure.2011.03.008","article-title":"Low glycemic index diet in children and young adults with refractory epilepsy: first Italian experience","volume":"20","author":"G Coppola","year":"2011","journal-title":"Seizure"}],"container-title":["Neuropediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/s-0044-1787744.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T15:00:54Z","timestamp":1730818854000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/s-0044-1787744"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,21]]},"references-count":18,"journal-issue":{"issue":"05","published-online":{"date-parts":[[2024,9,9]]},"published-print":{"date-parts":[[2024,10]]}},"URL":"https:\/\/doi.org\/10.1055\/s-0044-1787744","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0174-304X","1439-1899"],"issn-type":[{"value":"0174-304X","type":"print"},{"value":"1439-1899","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,21]]}}}